SCHEMBL9719112

SCHEMBL9719112

COc1cc([N+](=O)[O-])c2nccc(C)c2c1OCCCCCCCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 4/20 0.41
PDE4B Q07343 4/20 0.41
PDE4C Q08493 4/20 0.41
PDE4D Q08499 4/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP11B1 P15538 4/20 0.39
CYP11B2 P19099 4/20 0.39
HTR1A P08908 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
F2 P00734 1/20 0.39
ELANE P08246 1/20 0.39
CYP19A1 P11511 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
TXNRD1 Q16881 1/20 0.38
MAPT P10636 2/20 0.37
CTSD P07339 1/20 0.37
CTSB P07858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9719246 1.00 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL9719159 1.00 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL9719136 1.00 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL9719167 1.00 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL9719156 0.99 ALDH1A1 (0.40) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL9719192 0.96 CYP11B1 (0.41) ALDH1A1CYP11B1CYP11B2HTR1AADRA1D
SCHEMBL10942288 0.87 SMN1; SMN2 (0.39) TXNRD1MAPTCTSB
SCHEMBL10949604 0.87 SMN1; SMN2 (0.39) TXNRD1MAPTCTSB
SCHEMBL10949964 0.87 SMN1; SMN2 (0.39) TXNRD1MAPTCTSB
SCHEMBL9719144 0.86 TXNRD1 (0.37) ALDH1A1NPC1RAB9ATXNRD1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5104885-A 5-(phenylalkoxy)primaquine and 5[(heterocycle)alkoxy] primaquine compounds and their use for treatment of malaria CALSPAN CORPORATION (US) 1992-04-14 US disclosed
US-4980360-A NONTOXIC AT HIGHER DOSAGES CALSPAN CORPORATION (US) 1990-12-25 US disclosed